索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]庄玲芳,陈康.心型脂肪酸结合蛋白的临床应用[J].国际心血管病杂志,2017,06:344-347.
点击复制

心型脂肪酸结合蛋白的临床应用(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2017年06期
页码:
344-347
栏目:
综述
出版日期:
2017-11-25

文章信息/Info

Title:
-
作者:
庄玲芳; 陈康
200025 上海交通大学医学院附属瑞金医院心脏科
Author(s):
-
关键词:
心型脂肪酸结合蛋白;  心肌梗死;  代谢
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2017.06.007
文献标识码:
A
摘要:
心型脂肪酸结合蛋白(HFABP)是低分子量蛋白质,在心肌细胞中广泛表达,对细胞中长链脂肪酸的转运和氧化起着至关重要的作用。越来越多的研究表明,HFABP除了转运脂质外,还有许多其他的生物学功能,HFABP与心肌梗死、肺栓塞等疾病的诊断和预后有密切关系。
Abstract:
-

参考文献/References

[1] Smathers RL, Petersen DR. The human fatty acid-binding protein family: evolutionary divergences and functions[J]. Hum Genomics, 2011, 5(3):170-191.
[2] Ockner RK, Manning JA, Poppenhausen RB, et al. A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium, and other tissues[J]. Science, 1972, 177(4043):56-58.
[3] Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets[J]. Nat Rev Drug Discov, 2008, 7(6):489-503.
[4] Offner GD, Troxler RF, Brecher P. Characterization of a fatty acid-binding protein from rat heart[J]. J Biol Chem, 1986, 261(12):5584-5589.
[5] Haunerland NH, Spener F. Fatty acid-binding proteins--insights from genetic manipulations[J]. Prog Lipid Res, 2004, 43(4):328-349.
[6] Gillilan RE, Ayers SD, Noy N. Structural basis for activation of fatty acid-binding protein 4[J]. J Mol Biol, 2007, 372(5):1246-1260.
[7] Yang Y, Spitzer E, Kenney N, et al. Members of the fatty acid binding protein family are differentiation factors for the mammary gland[J]. J Cell Biol, 1994, 127(4):1097-1109.
[8] Ma X, Ren X, Han P, et al. SiRNA against Fabp5 induces 3T3-L1 cells apoptosis during adipocytic induction[J]. Mol Biol Rep, 2010, 37(8):4003-4011.
[9] Levi L, Wang Z, Doud MK, et al. Saturated fatty acids regulate retinoic acid signalling and suppress tumorigenesis by targeting fatty acid-binding protein 5[J]. Nat Commun, 2015, 6:8794.
[10] Yarla NS, Bishayee A, Sethi G,et al. Targeting arachidonic acid pathway by natural products for cancer prevention and therapy[J]. Semin Cancer Biol, 2016, 40-41:48-81.
[11] Song GX, Shen YH, Liu YQ, et al. Overexpression of FABP3 promotes apoptosis through inducing mitochondrial impairment in embryonic cancer cells[J]. J Cell Biochem, 2012, 113(12):3701-3708.
[12] Hashimoto T, Kusakabe T, Sugino T, et al. Expression of heart-type fatty acid-binding protein in human gastric carcinoma and its association with tumor aggressiveness, metastasis and poor prognosis[J]. Pathobiology, 2004,71(5):267-273.
[13] Wang S, Zhou Y, Andreyev O, et al. Overexpression of FABP3 inhibits human bone marrow derived mesenchymal stem cell proliferation but enhances their survival in hypoxia[J]. Exp Cell Res, 2014, 323(1):56-65.
[14] Okamoto F, Sohmiya K, Ohkaru Y, et al. Human heart-type cytoplasmic fatty acid-binding protein(H-FABP)for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB[J]. Clin Chem Lab Med, 2000,38(3):231-238.
[15] Meng X, Ming M, Wang E. Heart fatty acid binding protein as a marker for postmortem detection of early myocardial damage[J]. Forensic Sci Int, 2006, 160(1):11-16.
[16] Liao J, Chan CP, Cheung YC, et al. Human heart-type fatty acid-binding protein for on-site diagnosis of early acute myocardial infarction[J]. Int J Cardiol, 2009, 133(3):420-423.
[17] Collinson P, Gaze D, Goodacre S. Comparison of contemporary troponin assays with the novel biomarkers, heart fatty acid binding protein and copeptin, for the early confirmation or exclusion of myocardial infarction in patients presenting to the emergency department with chest pain[J]. Heart, 2014, 100(2):140-145.
[18] Gerede DM, Güle S, Kili kap M, et al. Comparison of a qualitative measurement of heart-type fatty acid-binding protein with other cardiac markers as an early diagnostic marker in the diagnosis of non-ST-segment elevation myocardial infarction[J]. Cardiovasc J Afr, 2015, 26(6):204-209.
[19] Glatz JF, van der Vusse GJ, Simoons ML, et al. Fatty acid-binding protein and the early detection of acute myocardial infarction[J]. Clin Chim Acta, 1998, 272(1):87-92.
[20] Haastrup B, Gill S, Kristensen SR, et al. Biochemical markers of ischaemia for the early identification of acute myocardial infarction without ST segment elevation[J]. Cardiology, 2000, 94(4):254-261.
[21] Liou K, Ho S, Ooi SY. Heart-type fatty acid binding protein in early diagnosis of myocardial infarction in the era of high-sensitivity troponin: a systematic review and meta-analysis[J]. Ann Clin Biochem, 2015, 52(Pt 3):370-381.
[22] Xu LQ, Yang YM, Tong H, et al. Early diagnostic performance of heart-type fatty acid binding protein in suspected acute myocardial infarction: evidence from a meta-analysis of contemporary studies[J]. Heart Lung Circ, 2017, May 4. [Epub ahead of print].
[23] Bruins Slot MH, Reitsma JB, Rutten FH, et al. Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction: a systematic review and meta-analysis[J]. Heart, 2010, 96(24):1957-1963.
[24] Kilcullen N, Viswanathan K, Das R, et al. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values[J]. J Am Coll Cardiol, 2007, 50(21):2061-2067.
[25] O’Donoghue M, de Lemos JA, Morrow DA, et al. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes[J]. Circulation, 2006, 114(6):550-557.
[26] Puls M, Dellas C, Lankeit M, et al. Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism[J]. Eur Heart J, 2007, 28(2):224-229.
[27] Dellas C, Puls M, Lankeit M, et al. Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism[J]. J Am Coll Cardiol, 2010, 55(19):2150-2157.
[28] Setsuta K, Seino Y, Mizuno K. Heart-type fatty acid-binding protein is a novel prognostic marker in patients with essential hypertension[J]. Int J Cardiol, 2014, 176(3):1323-1325.
[29] Gedikli O, Ozturk S, Yilmaz H, et al. Relationship between arterial stiffness and myocardial damage in patients with newly diagnosed essential hypertension[J]. Am J Hypertens, 2008, 21(9):989-993.
[30] Daidoji H, Arimoto T, Iwayama T, et al. Circulating heart-type fatty acid-binding protein levels predict ventricular fibrillation in Brugada syndrome[J]. J Cardiol, 2016, 67(3):221-228.
[31] Murphy EJ, Owada Y, Kitanaka N, et al. Brain arachidonic acid incorporation is decreased in heart fatty acid binding protein gene-ablated mice[J]. Biochemistry, 2005, 44(16):6350-6360.
[32] Veerkamp JH, Zimmerman AW. Fatty acid-binding proteins of nervous tissue[J]. J Mol Neurosci, 2001, 16(2/3):133-142; discussion 151-157.
[33] Chiasserini D, Biscetti L, Eusebi P, et al. Differential role of CSF fatty acid binding protein 3, alpha-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia[J]. Alzheimers Res Ther, 2017,9(1):52.
[34] Shioda N, Yabuki Y, Kobayashi Y, et al. FABP3 protein promotes alpha-synuclein oligomerization associated with 1-methyl-1,2,3,6-tetrahydropiridine-induced neurotoxicity[J]. J Biol Chem, 2014, 289(27):18957-18965.
[35] Tang Z, Shen Q, Xie H, et al. Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer(NSCLC)[J]. Oncotarget, 2016, 7(29):46253-46262.

备注/Memo

备注/Memo:
通信作者:陈康,Email:chenkang1978@163.com
更新日期/Last Update: 2017-12-10